Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

MicroRNAs: A potential new frontier for medicine

24.03.2011
Noted experts explore this topic in the April issue of Translational Research

Since their discovery in the 1990s, microRNAs have proven to play a complex role in normal and abnormal functioning of many organ systems. In the April issue of Translational Research, entitled "MicroRNAs: A Potential New Frontier for Medicine," an international group of medical experts explores several themes related to our current understanding of microRNAs and the role they may play in the future of medicine.

A commentary by Monty Montano, Department of Medicine, Boston University, provides a general introduction to this single-topic issue. He states, "In the coming years, there is much to be learned about adaptive (and maladaptive) states by examining how the expression of miRNAs is influenced by the genetic architecture of miR genes, clusters, and mirtrons, as well as miRNA polymorphism and polymorphism in their mRNA targets…Current efforts to leverage knowledge of this regulatory system to diagnose, track, and attenuate disease progression represent a major new research opportunity and challenge in this rapidly growing area of translational medicine."

KEY POINTS:

microRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases
Rujuan Dai, and S. Ansar Ahmed
The authors review in great detail the functions of microRNAs in autoimmune diseases, inflammation processes, and immune system regulation.
Integrating microRNAs into a system biology approach to acute lung injury
Tong Zhou, Joe G.N. Garcia and Wei Zhang
The authors explore the possible role of microRNAs in inflammatory lung diseases and integration into a comprehensive disease model for acute lung injury.
MicroRNAs in idiopathic pulmonary fibrosis
Kusum V. Pandit, Jadranka Milosevic and Naftali Kaminski
The authors summarize current knowledge on the role of microRNAs in idiopathic lung fibrosis (IPF), highlighting how differentially expressed microRNAs in IPF will have a significant impact on our understanding of the disease.
Involvement of microRNAs in lung cancer biology and therapy
Xi Liu, Lorenzo F. Sempere, Yongli Guo, Murray Korc, Sakari Kauppinen, Sarah J. Freemantle and Ethan Dmitrovsky

The authors review how microRNAs can accelerate or suppress lung cancers and how this knowledge might serve as a basis for developing diagnostic markers or anti-cancer therapeutic agents.

MicroRNA biomarkers in lung cancer: MiRacle or quagMiRe?
Sai Yendamuri and Robert Kratzke
The authors explore some of the difficulties facing the development of microRNAs as biomarkers for lung disease, as well as some promising areas of research.
MicroRNAs as therapeutic targets in cancer
S. Patrick Nana-Sinkam and Carlo M. Croce
The authors review the challenges of translating current knowledge on microRNAs into effective clinical therapies for many cancers or as adjuvants for enhancing chemosensitivity to traditional therapies.
MicroRNAs in cardiac disease
Gerald W. Dorn II
The author examines the use of microRNAs as both biomarkers of cardiac diseases and as potential targets for therapies.
MicroRNAs in kidney function and disease
Sanjeev Akkina and Bryan N. Becker
The authors review the role of microRNAs in understanding the pathophysiology of kidney disease and potential therapeutic uses.
microRNAs and liver disease
Thomas A. Kerr, Kevin M. Korenblat and Nicholas O. Davidson
The authors review developments in microRNA research in the areas of pathogenesis of nonalcoholic fatty liver disease (NAFLD), viral hepatitis (C and B), and hepatocellular carcinoma (HCC), as well as the role of miRNAs as biomarkers of liver injury and HCC.
Diabetes mellitus, a microRNA-related disease?
Claudiane Guay, Elodie Roggli, Valeria Nesca, Cécile Jacovetti and Romano Regazzi

The authors review recent studies on the role of microRNAs in the pathogenesis of diabetes, including the role of several microRNAs in pancreatic beta cells and insulin-target tissues.

These articles appear in Translational Research, The Journal of Laboratory and Clinical Medicine, Volume 157, Issue 4 (April 2011) entitled "MicroRNAs: A Potential New Frontier for Medicine," published by Elsevier.

Pat Hogan | EurekAlert!
Further information:
http://www.elsevier.com

More articles from Health and Medicine:

nachricht NTU scientists build new ultrasound device using 3-D printing technology
07.12.2016 | Nanyang Technological University

nachricht How to turn white fat brown
07.12.2016 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

NTU scientists build new ultrasound device using 3-D printing technology

07.12.2016 | Health and Medicine

The balancing act: An enzyme that links endocytosis to membrane recycling

07.12.2016 | Life Sciences

How to turn white fat brown

07.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>